Encrantz Staffan
SEC Form 4 insider trading activity
Encrantz Staffan has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 11, 2026.
On the most recent filing, Encrantz Staffan is listed as Director, 10% Owner at Sight Sciences, Inc. Inside the rolling window, Encrantz Staffan reported 2 open-market purchases totaling $185K in SGHT and no open-market sales. The largest disclosed transaction in the window is a purchase of 13,958 SGHT shares on Dec 16, 2025, worth $116K.
Companies traded
Other insiders at SGHT
Insider Buying
$185K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Encrantz Staffan made?
Encrantz Staffan has filed 3 SEC Form 4 filings (3 transaction rows) across 1 company since 2025.
Which companies does Encrantz Staffan trade?
Encrantz Staffan has filed SEC Form 4 disclosures for 1 company, including SGHT.
When was Encrantz Staffan's most recent SEC Form 4 filing?
Encrantz Staffan's most recent SEC Form 4 filing on Tracefour is dated Jun 11, 2026.
What is Encrantz Staffan's total buy and sell value in the current window?
Inside the rolling retention window, Encrantz Staffan bought $185K and sold $0 based on SEC Form 4 filings.
What was Encrantz Staffan's largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 13,958 SGHT shares on 2025-12-16, worth $116K, per SEC Form 4 filings.